Full-Time

IP Attorney/Patent Agent

Posted on 8/21/2024

Shape Therapeutics

Shape Therapeutics

51-200 employees

Develops programmable RNA medicines using AI

AI & Machine Learning
Biotechnology

Compensation Overview

$180k - $270kAnnually

+ Annual Target Bonus + Sign-On Bonus + Equity Grant + Relocation Bonus

Senior

Seattle, WA, USA

Category
Legal
Intellectual Property (IP)
Legal & Compliance
Required Skills
Business Strategy
Requirements
  • 5+ years of experience in creating, preparing, prosecuting, and advising on complex life science patent portfolios and IP strategy. Gene therapy experience is a plus.
  • Advanced degree in relevant life science scientific or technical field and a strong technological aptitude for learning and working with a range of technologies
  • Experience and expertise in global patent portfolio preparation and prosecution for inventions involving life sciences, including therapeutic molecules and related technologies
  • Experience and expertise in conducting patent database searches and rapidly parsing through large amounts of information to identify relevant material
  • Experience providing advice on complex licensing and/or other transactional matters is a plus
  • Record of success in innovating and creating business value, fostering teamwork and collaboration with other teams, and influencing and resolving conflict
  • Ability to work independently and proactively with minimal direction
  • Excellent judgment, pragmatism, and negotiation skills
  • Strong organizational skills, keen attention to detail, and ability to prioritize projects and meet rapid deadlines
  • Proven record as an adaptive and results-oriented performer, which includes balancing competing priorities, working effectively both independently and in global and cross-functional teams, and managing external relationships with outside counsel and collaborators.
Responsibilities
  • Develop an understanding of the science, technology, and business strategy to inform both IP strategy as well as business decision-making processes.
  • Carry out IP searching and/or landscaping, due diligence assessments, freedom-to-operate, infringement, validity analyses, patent drafting and preparation of patent prosecution documents, as needed.
  • Support court and administrative litigation efforts in the US and globally
  • Advise on data protection and other forms of exclusivity
  • Advise business stakeholders on IP strategies and risks
  • Provide IP diligence, advice, and strategy regarding business development and research in support of research collaborations and licensing opportunities.
  • Direct and manage outside counsel, related budgets and where applicable negotiate rates, project fees, and timelines, as applicable.

Shape Therapeutics specializes in programmable RNA medicine, using artificial intelligence to analyze large datasets for new drug development. Their technology, RNAfix, modifies RNA instructions to correct genetic mutations without changing DNA, while smart-sensing vector designs allow for tailored gene expression in specific cell types. The company aims to create effective and safe medicines that address the root causes of diseases, distinguishing itself through its focus on AI-driven RNA technology.

Company Stage

Series B

Total Funding

$143.5M

Headquarters

Seattle, Washington

Founded

2018

Growth & Insights
Headcount

6 month growth

0%

1 year growth

5%

2 year growth

23%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased interest in RNA therapies boosts ShapeTX's market potential and investment opportunities.
  • FDA fast-tracking of RNA therapies could expedite ShapeTX's clinical trial processes.
  • Collaborations with tech giants can enhance ShapeTX's AI capabilities for drug discovery.

What critics are saying

  • Intellectual property disputes in biotech could threaten ShapeTX's proprietary technologies.
  • Rapid technological advancements may render ShapeTX's current platforms obsolete without continuous innovation.
  • Intensifying regulatory scrutiny on gene editing could delay ShapeTX's clinical trials.

What makes Shape Therapeutics unique

  • ShapeTX uses AI to design novel RNAs for reprogramming cells against diseases.
  • Their RNAfix technology corrects RNA without altering DNA, offering unique therapeutic potential.
  • Smart-sensing vector designs enable precise gene expression, surpassing first-generation gene therapies.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE